Sirolimus in Liver Transplant Recipients With Hepatocellular Carcinoma

被引:3
|
作者
Grigg, Sam [1 ]
Gow, Paul [2 ]
Yeomans, Neville [1 ]
机构
[1] Univ Melbourne, Parkville, Vic, Australia
[2] Austin Hlth, Liver Transplant Unit, Heidelberg, Vic, Australia
关键词
IMMUNOSUPPRESSION; SURVIVAL; RECURRENCE;
D O I
10.1080/08941939.2018.1513103
中图分类号
R61 [外科手术学];
学科分类号
摘要
引用
收藏
页码:389 / 390
页数:2
相关论文
共 50 条
  • [1] Letter: the effect of sirolimus on recurrence and survival in liver transplant recipients with hepatocellular carcinoma
    Grigg, Sam
    Gow, Paul J.
    Yeomans, Neville
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2018, 48 (11-12) : 1330 - 1331
  • [2] Sirolimus in Liver Transplant Recipients with Hepatocellular Carcinoma: An Updated Meta-Analysis
    Zhang, Zhi-Hua
    Li, Li Xin
    Li, Ping
    Lv, Shao-Cheng
    Pan, Bing
    He, Qiang
    [J]. JOURNAL OF INVESTIGATIVE SURGERY, 2019, 32 (07) : 632 - 641
  • [3] EVALUATION OF SIROLIMUS AND/OR CELECOXIB TO PREVENT HEPATOCELLULAR CARCINOMA IN LIVER TRANSPLANT RECIPIENTS: A PILOT STUDY
    Aloia, Thomas A.
    Goss, John A.
    Michel, David
    Haykal, Nadine
    Galati, Joseph
    Gaber, Ahmed O.
    Ghobrial, R. M.
    [J]. LIVER TRANSPLANTATION, 2009, 15 (07) : S200 - S200
  • [4] Sirolimus from the early postoperative in liver transplant recipients with high-risk hepatocellular carcinoma
    Vivarelli, Marco
    Dazzi, Alessandro
    Cucchetti, Alessandro
    Zanello, Matteo
    La Barba, Giuliano
    Vetrone, Gaetano
    Cescon, Matteo
    Del Gaudio, Massimo
    Ercolani, Giorgio
    Lauro, Augusto
    Ravaioi, Matteo
    Grazi, Gian Luca
    Pinna, Antonio D.
    [J]. TRANSPLANT INTERNATIONAL, 2007, 20 : 121 - 121
  • [5] Letter: the effect of sirolimus on recurrence and survival in liver transplant recipients with hepatocellular carcinoma-authors' reply
    Menon, Krishna V.
    Hakeem, Abdul R.
    Heaton, Nigel D.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2018, 48 (11-12) : 1331 - 1332
  • [6] Strategies of Immunosuppression for Liver Transplant Recipients With Hepatocellular Carcinoma
    Castroagudin, J. F.
    Molina-Perez, E.
    Ferreiro-Iglesias, R.
    Varo-Perez, E.
    [J]. TRANSPLANTATION PROCEEDINGS, 2011, 43 (03) : 711 - 713
  • [7] Sirolimus Monotherapy in Liver Transplant Recipients
    Ju, Weiqiang
    He, Xiaoshun
    Guo, Zhiyong
    Wu, Linwei
    Tai, Qiang
    [J]. LIVER TRANSPLANTATION, 2010, 16 (06) : S230 - S230
  • [8] Is sirolimus nephrotoxic in liver transplant recipients?
    Smallwood, GA
    Fasola, C
    Stieber, AC
    Heffron, TG
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 : 573 - 573
  • [9] Effects of Maintenance Immunosuppression With Sirolimus After Liver Transplant for Hepatocellular Carcinoma
    Yanik, Elizabeth L.
    Chinnakotla, Srinath
    Gustafson, Sally K.
    Snyder, Jon J.
    Israni, Ajay K.
    Segev, Dorry L.
    Engels, Eric A.
    [J]. LIVER TRANSPLANTATION, 2016, 22 (05) : 627 - 634
  • [10] Recurrent hepatocellular carcinoma in liver transplant recipients with hepatitis C
    Zendejas, Ivan
    Mizuno, Shugo
    Fujita, Shiro
    Kayler, Liise K.
    Magliocca, Joseph F.
    Reed, Alan I.
    Firpi, Roberto
    Cabrera, Ron
    Soldevila-Pico, Consuelo
    Nelson, David
    Hemming, Alan W.
    Kim, Robin D.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 : 382 - 382